Keyword: Novartis

Startup H1 landed $12.9 million in a Series A funding round to scale up its digital professional database for pharmaceutical and biotech.

Digital primary care service K Health scored $48 million in series C funding, Alto Pharmacy landed $250 million, and more funding news.

A new report from OptumRx highlights five drugs that it expects to make a big splash in the market.

Digital health startup Xealth has raised $11 million from Novartis, a digital therapeutics company, and medical device companies Philips and ResMed.

In-person and electronic communications between more than 30 companies reveal a plot to cause extreme price increases and eliminate competition, the complaint says.

Due to benefit changes, some patients are spending much more out of pocket for drugs, even with copay assistance.

The costs of the country’s first gene therapy will be higher than many imagined, reaching $1 million or more per patient, say leading cancer experts.

A new consortium of payers, providers and manufacturers at Duke University has highlighted data as one of the key barriers to value-based agreements.

President Trump maintained a pledge from his election campaign and told big pharmaceutical companies they must make prescription drugs more affordable.